L L Truex - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

Neurobiology of Aging|January 1, 1980

3H-amphetamine concentrations in the brains of young and aged rats: implications for assessment of drug effects in aged animalsL L Truex, M J Schmidt

Journal of Neurochemistry|July 1, 1980

Cyclic AMP-dependent protein kinase activity in human brain across ageM J Schmidt, L L Truex, B Ghetti, et al.

Journal of Medicinal Chemistry|October 1, 1987

Evaluation of isomeric 4-(chlorohydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines as dopamine D-1 antagonistsR M Riggs, D E Nichols, M M Foreman, et al.

Acta Neuropathologica|January 1, 1994

Neuronal vacuole formation in the rat posterior cingulate/retrosplenial cortex after treatment with the N-methyl-D-aspartate (NMDA) antagonist MK-801 (dizocilpine maleate)A S Fix, J W Horn, L L Truex, et al.

The Journal of Pharmacology and Experimental Therapeutics|March 1, 1985

LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphateM J Schmidt, B D Sawyer, L L Truex, et al.

Journal of Cyclic Nucleotide Research|June 1, 1978

Effect of lin-benzoadenosine and lin-benzoadenosine 3':5'-monophosphate on cyclic AMP-dependent protein kinase activity in vitroM J Schmidt, L L Truex, N J Leonard, et al.

Journal of Medicinal Chemistry|February 1, 1990

Aporphines as antagonists of dopamine D-1 receptorsJ M Schaus, R D Titus, M M Foreman, et al.

Brain Research|October 23, 1995

Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortexA S Fix, D F Wozniak, L L Truex, et al.

Journal of Medicinal Chemistry|August 1, 1987

Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3-c]pyridine analogueR M Riggs, D E Nichols, M M Foreman, et al.

Journal of Medicinal Chemistry|October 1, 1987

Effect of beta-alkyl substitution on D-1 dopamine agonist activity: absolute configuration of beta-methyldopamineR M Riggs, A T McKenzie, S R Byrn, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

Neurobiology of Aging|January 1, 1980

3H-amphetamine concentrations in the brains of young and aged rats: implications for assessment of drug effects in aged animalsL L Truex, M J Schmidt

Journal of Neurochemistry|July 1, 1980

Cyclic AMP-dependent protein kinase activity in human brain across ageM J Schmidt, L L Truex, B Ghetti, et al.

Journal of Medicinal Chemistry|October 1, 1987

Evaluation of isomeric 4-(chlorohydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines as dopamine D-1 antagonistsR M Riggs, D E Nichols, M M Foreman, et al.

Acta Neuropathologica|January 1, 1994

Neuronal vacuole formation in the rat posterior cingulate/retrosplenial cortex after treatment with the N-methyl-D-aspartate (NMDA) antagonist MK-801 (dizocilpine maleate)A S Fix, J W Horn, L L Truex, et al.

The Journal of Pharmacology and Experimental Therapeutics|March 1, 1985

LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphateM J Schmidt, B D Sawyer, L L Truex, et al.

Journal of Cyclic Nucleotide Research|June 1, 1978

Effect of lin-benzoadenosine and lin-benzoadenosine 3':5'-monophosphate on cyclic AMP-dependent protein kinase activity in vitroM J Schmidt, L L Truex, N J Leonard, et al.

Journal of Medicinal Chemistry|February 1, 1990

Aporphines as antagonists of dopamine D-1 receptorsJ M Schaus, R D Titus, M M Foreman, et al.

Brain Research|October 23, 1995

Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortexA S Fix, D F Wozniak, L L Truex, et al.

Journal of Medicinal Chemistry|August 1, 1987

Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3-c]pyridine analogueR M Riggs, D E Nichols, M M Foreman, et al.

Journal of Medicinal Chemistry|October 1, 1987

Effect of beta-alkyl substitution on D-1 dopamine agonist activity: absolute configuration of beta-methyldopamineR M Riggs, A T McKenzie, S R Byrn, et al.

Pageof 2